Fig. 3: Longitudinal SARS-CoV-2 neutralization by sera from AZD1222 vaccinated individuals in two west African countries stratified by N antibody status at baseline.
From: SARS-COV-2 antibody responses to AZD1222 vaccination in West Africa
a Neutralisation titres before and after vaccine (n = 49) stratified by N antibodies at baseline in Nigerian participants. b Neutralisation titres before and after vaccine (n = 45) stratified by N antibodies at baseline in Ghanaian participants. Data points were compared using Wilcoxon test and shown as geometric mean titre (GMT) with 95% CI. Data are representative of two independent experiments comprising of two technical replicates. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001; ns = not significant.
